Active disease in juvenile idiopathic arthritis: current patterns and associations: a one-year study

Sajib M. Rayhan; M. Imnul Islam; Mohammad H. Kabir; Mahfuza Akter

doi:10.18203/2349-3291.ijcp20230076

Authors

Sajib M. Rayhan Sonargaon Upazila Health Complex, Narayanganj, Bangladesh
M. Imnul Islam Department of Paediatrics, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Mohammad H. Kabir Department of Pediatrics, Colonel Malek Medical College, Manikganj, Bangladesh
Mahfuza Akter Department of Ophthalmology, Mugda Medical College and Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230076

Keywords:

Juvenile idiopathic arthritis, Pathogenesis, Active disease

Abstract

Background: Juvenile idiopathic arthritis (JIA) is the most common rheumatic ailment of children. JIA is characterized by idiopathic peripheral arthritis with an immunoinflammatory pathogenesis possibly activated by contact with external antigens. To describe the success of active disease (AD) and remission in polyarticular juvenile idiopathic arthritis (JIA) and to measure the associations among patient characteristics, imaging results and these outcomes. The aim of this study is to assess the Active disease in juvenile idiopathic arthritis: current patterns and associations.

Methods: This is an observational study. The study used to be carried out in the admitted patient’s Department of pediatrics, Bangabandhu Sheikh Mujib Medical University (BSMMU), Bangladesh. In Bangladesh for the duration of the period from October 2015 to March 2017.

Results: This study shows that the according to age of 33 patients aged 1 to 9 years. Here according to age distribution, 2 (6.1%) were 1-3 years, 10 (30.30%) were >3‑6 years, 9 (27.27%) were >6-9 years and 12 (36.4%) were >9 years. And according to gender 13 (39.4%) were male and 20 (60.6%) were female.

Conclusions: Children with polyarticular JIA spent the majority of their follow-up with active disease. Because children with early radiographic evidence of joint damage have the most active disease, improving outcomes for these subgroups may be an important goal for prospective study.

Metrics

Metrics Loading ...

References

Denardo BA, Tucker LB, Miller LC, Szer IS, Schaller JG. Demography of a regional pediatric rheumatology patient population. Affiliated Children's Arthritis Centers of New England. J Rheumatol. 1994;21(8):1553-61.

Oen KG, Cheang M. Epidemiology of chronic arthritis in childhood. In Seminars in arthritis and rheumatism. 1996;26(3):575-91.

Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol. 1996;23(11):1981-7.

Arkela-Kautiainen M, Haapasaari J, Kautiainen H, Vilkkumaa I, Mälkiä E, Leirisalo-Repo M. Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheumat Dis. 2005;64(6):875-80.

Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, et al. Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatric Rheumatol. 2017;15(1):1-8.

Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29(9):1989-99.

Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long‐term follow‐up study. Rheumatology. 2000;39(2):198-204.

Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization and Pediatric Rheumatology Collaborative Study Group, 2004. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290-4.

Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis & Rheumatism. 2005;52(11):3554-62.

Ravelli A, Martini A. Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2003;21(5):S89-93.

FlatØ B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol. 2003;30(2):386-93.

Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Reed M, et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J Rheumatol. 2003;30(3):585-93.

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-2.

Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R. Summarizing data on survival, relapse, and chronic graft‐versus‐host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol. 1993;83(4):602-7.

Pepe MS, Longton G, Thornquist M. A qualifier Q for the survival function to describe the prevalence of a transient condition. Statistics Med. 1991;10(3):413-21.

Fernandes TA, Corrente JE, Magalhães CS. Remission status follow-up in children with juvenile idiopathic arthritis. J Pediatrics. 2007;83:141-8.

Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, et al. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003;30(2):394-400.

Mason T, Reed AM, Nelson AM, Thomas KB. Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study. Ann Rheum Dis. 2005;64(3):491-3.

Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology E-Book. Elsevier Health Sciences. 2010.

Stoll ML, Li QZ, Zhou J, Punaro M, Olsen NJ. Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course. Clin Exp Rheumatol. 2011;29(4):736.

de la Torre I, Leandro MJ, Edwards JC, Cambridge G. Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab. Clin Exp Rheumatol. 2012;30(4):554.

Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediators Inflamm. 2012;714732.

Aho K, Heliövaara M, Knekt P, Reunanen A, Aromaa A, Leino A, et al. Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis. 1997;56(6):351-6.

de la Torre I, Leandro MJ, Edwards JC, Cambridge G. Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab. Clin Exp Rheumatol. 2012;30(4):554.

Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheumatism. 1995;38(4):499-505.

Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology E-Book. Elsevier Health Sciences. 2010.

Jednacz E, Rutkowska-Sak L. Atherosclerosis in juvenile idiopathic arthritis. Mediators Inflamm. 2012;714732.